Cargando…

Drug Discovery Using Chemical Systems Biology: Repositioning the Safe Medicine Comtan to Treat Multi-Drug and Extensively Drug Resistant Tuberculosis

The rise of multi-drug resistant (MDR) and extensively drug resistant (XDR) tuberculosis around the world, including in industrialized nations, poses a great threat to human health and defines a need to develop new, effective and inexpensive anti-tubercular agents. Previously we developed a chemical...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kinnings, Sarah L., Liu, Nina, Buchmeier, Nancy, Tonge, Peter J., Xie, Lei, Bourne, Philip E.
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2009
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2699117/ https://www.ncbi.nlm.nih.gov/pubmed/19578428 http://dx.doi.org/10.1371/journal.pcbi.1000423

Ejemplares similares

Drug repositioning in drug discovery of T2DM and repositioning potential of antidiabetic agents
por: Zhu, Sha, et al.
Publicado: (2022)

DrugCentral 2021 supports drug discovery and repositioning
por: Avram, Sorin, et al.
Publicado: (2020)

Drug–Target Kinetics in Drug Discovery
por: Tonge, Peter J.
Publicado: (2017)

Repositioning Natural Products in Drug Discovery
por: Rastelli, Giulio, et al.
Publicado: (2020)

Recent Advances in Drug Repositioning for the Discovery of New Anticancer Drugs
por: Shim, Joong Sup, et al.
Publicado: (2014)

Drug repositioning: Progress and challenges in drug discovery for various diseases
por: Hua, Yi, et al.
Publicado: (2022)

PROMISCUOUS: a database for network-based drug-repositioning
por: von Eichborn, Joachim, et al.
Publicado: (2011)

Three-Dimensional in Vitro Cell Culture Models in Drug Discovery and Drug Repositioning
por: Langhans, Sigrid A.
Publicado: (2018)

Drug repositioning can accelerate discovery of pharmacological chaperones
por: Hay Mele, Bruno, et al.
Publicado: (2015)

Large-scale Direct Targeting for Drug Repositioning and Discovery
por: Zheng, Chunli, et al.
Publicado: (2015)

Computational Discovery of Putative Leads for Drug Repositioning through Drug-Target Interaction Prediction
por: Coelho, Edgar D., et al.
Publicado: (2016)

A medicinal chemistry perspective of drug repositioning: Recent advances and challenges in drug discovery
por: Pillaiyar, Thanigaimalai, et al.
Publicado: (2020)

Quantifying Reproducibility in Computational Biology: The Case of the Tuberculosis Drugome
por: Garijo, Daniel, et al.
Publicado: (2013)

Epigenetic assays for chemical biology and drug discovery
por: Gul, Sheraz
Publicado: (2017)

Repositioning Drugs for Psychiatry
por: Akhondzadeh, Shahin
Publicado: (2020)

Editorial: Tuberculosis Drug Discovery & Development: Drug Targets, Chemical Matter, and Approaches
por: Singh, Vinayak
Publicado: (2021)

Repositioned Drugs for Chagas Disease Unveiled via Structure-Based Drug Repositioning
por: Adasme, Melissa F., et al.
Publicado: (2020)

A review on computer‐aided chemogenomics and drug repositioning for rational COVID‐19 drug discovery
por: Maghsoudi, Saeid, et al.
Publicado: (2022)

Old drug repositioning and new drug discovery through similarity learning from drug-target joint feature spaces
por: Zheng, Yi, et al.
Publicado: (2019)

Drug Discovery Using Chemical Systems Biology: Identification of the Protein-Ligand Binding Network To Explain the Side Effects of CETP Inhibitors
por: Xie, Li, et al.
Publicado: (2009)

Drug Discovery Using Chemical Systems Biology: Weak Inhibition of Multiple Kinases May Contribute to the Anti-Cancer Effect of Nelfinavir
por: Xie, Li, et al.
Publicado: (2011)

MicroRNA-Based Discovery of Biomarkers, Therapeutic Targets, and Repositioning Drugs for Breast Cancer
por: Ye, Qing, et al.
Publicado: (2023)

Discovery of therapeutic agents targeting PKLR for NAFLD using drug repositioning
por: Zhang, Cheng, et al.
Publicado: (2022)

Drug repositioning or target repositioning: A structural perspective of drug-target-indication relationship for available repurposed drugs
por: Parisi, Daniele, et al.
Publicado: (2020)

Harnessing Biological Insight to Accelerate Tuberculosis Drug Discovery
por: de Wet, Timothy J., et al.
Publicado: (2019)

Drug repositioning for personalized medicine
por: Li, Yvonne Y, et al.
Publicado: (2012)

Network mirroring for drug repositioning
por: Park, Sunghong, et al.
Publicado: (2017)

Drug Repositioning for COVID-19
por: Benavides-Cordoba, Vicente
Publicado: (2020)

GREP: genome for REPositioning drugs
por: Sakaue, Saori, et al.
Publicado: (2019)

Transcriptome-Guided Drug Repositioning
por: Arakelyan, Arsen, et al.
Publicado: (2019)

Drug Repositioning in Friedreich Ataxia
por: Rufini, Alessandra, et al.
Publicado: (2022)

System and network biology-based computational approaches for drug repositioning
por: Pandita, Vasundhara, et al.
Publicado: (2022)

Systematic Approach for Drug Repositioning of Anti-Epileptic Drugs
por: Ko, Younhee, et al.
Publicado: (2019)

New drugs are not enough-drug repositioning in oncology: An update
por: Armando, Romina Gabriela, et al.
Publicado: (2020)

MeSHDD: Literature-based drug-drug similarity for drug repositioning
por: Brown, Adam S, et al.
Publicado: (2017)

A Review of Current In Silico Methods for Repositioning Drugs and Chemical Compounds
por: He, Binsheng, et al.
Publicado: (2021)

In silico drug repositioning based on the integration of chemical, genomic and pharmacological spaces
por: Chen, Hailin, et al.
Publicado: (2021)

Overcoming Mycobacterium tuberculosis Drug Resistance: Novel Medications and Repositioning Strategies
por: Sachan, Rohan Samir Kumar, et al.
Publicado: (2023)

DPDR-CPI, a server that predicts Drug Positioning and Drug Repositioning via Chemical-Protein Interactome
por: Luo, Heng, et al.
Publicado: (2016)

Extensively Drug-Resistant Tuberculosis: A Sign of the Times and an Impetus for Antimicrobial Discovery
por: Haydel, Shelley E.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_2v2of83f0ndadcgntnmfd9e1rf